Alfresa Holdings Corporation
ARHCFOTCHealthcare● Active
$11.87
+$0.00(+0.00%)
Market Cap$2.2B
P/E Ratio—
52W High$11.87
52W Low$11.87
Alfresa Holdings Corporation (ARHCF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ARHCF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.042T | $0.039T | $0.044T | $0.039T | $0.048T |
| Depreciation & Amort. | $0.015T | $0.015T | $0.014T | $0.013T | $0.013T |
| Stock-Based Comp. | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Change in Working Capital | ($0.002T) | ($0.036T) | $0.044T | ($0.009T) | ($0.005T) |
| Net Cash from Operations | $0.039T | $0.006T | $0.086T | $0.013T | $0.037T |
| Investing Activities | |||||
| Capital Expenditure | ($0.023T) | ($0.020T) | ($0.015T) | ($0.025T) | ($0.017T) |
| Purchases of Investments | ($0.009T) | ($0.013T) | ($0.007T) | ($0.006T) | ($0.002T) |
| Sales of Investments | $0.032T | $0.008T | $0.008T | $0.011T | $0.026T |
| Net Cash from Investing | ($0.009T) | ($0.025T) | ($0.014T) | ($0.021T) | $0.002T |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.001T) | ($0.011T) | ($0.036T) | ($0.000T) | ($0.015T) |
| Dividends Paid | ($0.012T) | ($0.013T) | ($0.012T) | ($0.011T) | ($0.011T) |
| Debt Issued / Repaid | ($0.002T) | $0.000T | $0.030T | ($0.002T) | ($0.002T) |
| Net Cash from Financing | ($0.014T) | ($0.024T) | ($0.020T) | ($0.013T) | ($0.029T) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.016T | ($0.014T) | $0.071T | ($0.012T) | $0.020T |
| FCF Margin %(computed) | 0.52% | -0.49% | 2.49% | -0.46% | 0.76% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · JPY · T
Explore more Alfresa Holdings Corporation data
About Alfresa Holdings Corporation (ARHCF) Cash Flow Statement
Alfresa Holdings Corporation generated operating cash flow of $38.81B and free cash flow of $16.21B for 2026 — a FCF margin of 0.52%. Capital expenditure was ($22.60B).
Frequently asked questions
ARHCF · 4 questionsAlfresa Holdings Corporation generated free cash flow of $16.21B for 2026, up 211.9% year-over-year.
ARHCF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10